Archives

Working for healthcare at a social distance 572 168 Shields Health Solutions

Working for healthcare at a social distance

Every Excelera member is on the front line in the fight against the novel coronavirus (COVID-19). Our members are proactively addressing challenges as they relate to COVID by regularly sharing…

Hospitals adapt real estate to fit new normal after COVID-19 150 150 Shields Health Solutions

Hospitals adapt real estate to fit new normal after COVID-19
Health systems are reassessing their real estate portfolios as they prepare for a post-COVID-19 environment that will likely feature more home-based care and remote working arrangements.
How Health Systems Can Optimize Revenue Streams and Improve the Patient Experience by Providing Home Infusion Pharmacy Services 204 115 Shields Health Solutions

How Health Systems Can Optimize Revenue Streams and Improve the Patient Experience by Providing Home Infusion Pharmacy Services
This white paper describes the home infusion opportunity, outlines factors to consider in deciding whether to launch a home infusion program, and recommends resources. A case study describing an Excelera Home Infusion Solutions engagement is included. • Home infusion is a growing category. • Many health systems find that home infusion aligns with clinical and financial goals. • A consultant can help health systems get to market faster as they develop their in-house home infusion expertise.
Excelera® Welcomes Diane Wolfe as National Director of Manufacturer Relations 204 115 Shields Health Solutions

Excelera® Welcomes Diane Wolfe as National Director of Manufacturer Relations
Wolfe joins Excelera with significant experience in building strategic pharmaceutical manufacturer relationships for publicly traded and private organizations in the healthcare sector
Excelera Announces Key Hires to Support Expanded Product and Service Offerings 204 115 Shields Health Solutions

Excelera Announces Key Hires to Support Expanded Product and Service Offerings
Updates include additions to the leadership team, enhanced technology platform capabilities to track electronic health record data and expanded product portfolio
New Combination Therapies for the Treatment of Chronic Lymphocytic Leukemia 150 150 Shields Health Solutions

New Combination Therapies for the Treatment of Chronic Lymphocytic Leukemia
Erin Kelley, PharmD, BCOP, and Jeff Engle, PharmD, MS, Fairview Health CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) is the most common type of leukemia in adults and accounts for approximately 37% of new leukemia cases. An estimated 20,720 new cases of and 3930 deaths from CLL will occur in the United States in 2019.
Growth of Health System-Based Specialty Pharmacy to Continue in 2020, Reducing Cost of Care 150 150 Shields Health Solutions

Growth of Health System-Based Specialty Pharmacy to Continue in 2020, Reducing Cost of Care
By Don Amorosi, Chief Operating Officer; and Becky Rand, MHRM, Vice President of Manufacturer Relations ExceleraRx Corp Although the prevalence of health system-based specialty pharmacies has grown steadily over the past decade, 2020 will mark a critical year. Payers, providers, and health systems themselves are increasingly recognizing the important role integrated delivery solutions play in value-based care initiatives.
Excelera® Welcomes Experienced Healthcare Executive as National Vice President of Sales 204 115 Shields Health Solutions

Excelera® Welcomes Experienced Healthcare Executive as National Vice President of Sales
Meredith Holt joins Excelera with over 20 years of experience establishing and expanding health care initiatives, programs and relationships.
Excelera Expands Solutions for Members, Manufacturers and Payers, Improving Complex Patient Care in 2019 204 115 Shields Health Solutions

Excelera Expands Solutions for Members, Manufacturers and Payers, Improving Complex Patient Care in 2019
New specialty pharmacy services and products, health system members and top executive hires highlight 2019 accomplishments